These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8252271)

  • 21. Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?
    Murali R; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2012 Oct; 19(11):3310-2. PubMed ID: 22777079
    [No Abstract]   [Full Text] [Related]  

  • 22. Recurrence of cutaneous malignant melanoma after more than 20 years.
    Bredgaard R; Lock-Andersen J
    J Plast Surg Hand Surg; 2011 Apr; 45(2):113-6. PubMed ID: 21504283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An epidemiological study of the distinct histological types of cutaneous melanoma in relation to other variables of the disease].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Agudo Ferrándiz J; Segarra Castelló L
    Rev Clin Esp; 1992 Mar; 190(4):169-76. PubMed ID: 1589611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic study of recurrent Clark level II melanomas.
    Glass LF; Guffey JM; Schroer KR; Reintgen D
    Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
    Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
    J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical margins for excision of primary cutaneous melanoma.
    Zitelli JA; Brown CD; Hanusa BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thick malignant melanomas (greater than 3 mm Breslow) with good clinical outcome: a histological study and survival analysis.
    Blessing K; McLaren KM; McLean A; Davidson P
    Histopathology; 1991 Feb; 18(2):143-8. PubMed ID: 2010179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
    Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
    Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of stage I malignant melanoma].
    Fried G; Stein M; Borovik R; Ben Shachar M; Robinson E
    Harefuah; 1989 Sep; 117(5-6):130-3. PubMed ID: 2485754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome.
    Tas F; Erturk K
    Melanoma Res; 2017 Aug; 27(4):387-390. PubMed ID: 28234768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does localized melanoma of the foot have a poorer prognosis than melanoma of the leg?
    Corona R
    Arch Dermatol; 1999 Dec; 135(12):1529. PubMed ID: 10606061
    [No Abstract]   [Full Text] [Related]  

  • 36. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of thin cutaneous head and neck melanoma (<1mm).
    Andersson AP; Dahlstróm KK; Drzewiecki KT
    Eur J Surg Oncol; 1996 Feb; 22(1):55-7. PubMed ID: 8846868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
    Veronesi U; Cascinelli N; Adamus J; Balch C; Bandiera D; Barchuk A; Bufalino R; Craig P; De Marsillac J; Durand JC
    N Engl J Med; 1988 May; 318(18):1159-62. PubMed ID: 3079582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
    Kapelanski DP; Block GE; Kaufman M
    Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.